Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Flora Growth ( (FLGC) ) is now available.
Flora Growth Corp., which is transitioning its brand to ZeroStack, has launched an underwritten public offering of its common shares, with all shares to be issued by the company. The size and terms of the deal will depend on market conditions, and there is no certainty on timing or completion, but the offering is being conducted under an already effective shelf registration and will be led by R.F. Lafferty & Co. as sole book-running manager. The transaction is intended to tap public capital markets using existing SEC registration infrastructure, a move that could provide additional funding flexibility for the company as it advances its decentralized AI asset management strategy and expands its global pharmaceutical distribution operations.
The most recent analyst rating on (FLGC) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Flora Growth stock, see the FLGC Stock Forecast page.
Spark’s Take on FLGC Stock
According to Spark, TipRanks’ AI Analyst, FLGC is a Neutral.
The score is held down primarily by weak financial performance (ongoing losses, declining revenue, and negative free cash flow) and bearish technicals (price below key moving averages with negative MACD). Valuation is difficult to assess due to negative earnings and no dividend support. Offsetting factors include constructive corporate events that improve governance and provide financing flexibility.
To see Spark’s full report on FLGC stock, click here.
More about Flora Growth
Flora Growth Corp., set to be rebranded as ZeroStack, is a Nasdaq-listed asset management company focused on providing investor exposure to decentralized artificial intelligence. Alongside its AI-focused asset management operations, the company also runs a global pharmaceutical distribution business through its wholly owned German subsidiary, Phatebo GmbH, positioning it at the intersection of emerging AI-finance themes and traditional healthcare markets.
Average Trading Volume: 34,261
Technical Sentiment Signal: Sell
Current Market Cap: $6.61M
See more insights into FLGC stock on TipRanks’ Stock Analysis page.